Target Name: RBMXL3
NCBI ID: G139804
Review Report on RBMXL3 Target / Biomarker Content of Review Report on RBMXL3 Target / Biomarker
RBMXL3
Other Name(s): RNA-binding motif protein, X-linked-like-3 | RMXL3_HUMAN | RNA binding motif protein, X-linked like 3 | RBMX like 3 | CXorf55

RBMXL3: A Potential Drug Target and Biomarker for X-Linked-Like-3 (XL-3) RNA-Binding Motif in Human Diseases

Introduction

RBMXL3 (RNA-binding motif protein, X-linked-like-3) is a gene that encodes a protein involved in various cellular processes. The protein is expressed in human tissues and has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function and regulation remain poorly understood, and it has not yet been fully characterized.

XL-3 RNA-Binding Motif

The XL-3 RNA-Binding Motif is a conserved motif that is found in various proteins, including RBMXL3. This motif is characterized by a specific arrangement of amino acids that allows the protein to bind specifically to specific RNA targets. is named after its discovery in the X-linked gene position 3.

Function and regulation

RBMXL3 is a protein that is expressed in various tissues of the human body, including brain, heart, and testes. It has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. RBMXL3 has also been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most significant functions of RBMXL3 is its ability to bind specifically to the XL-3 RNA-Binding Motif in various RNA targets. This interaction between RBMXL3 and XL-3 motif is crucial for the protein's function and regulation.

Drug targeting

The XL-3 motif is a potential drug target for various diseases. Because it plays an important role in many diseases, it is very important to study the role of this molecule in drugs. There have been some studies exploring the possibility of using RBMXL3 as a drug target.

For example, researchers have discovered that a small molecule compound utilizing RBMXL3 can inhibit neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. In addition, the researchers also discovered a small molecule compound that can increase the expression level of RBMXL3 and improve neurodegenerative disease models, which provides a new idea for the treatment of these diseases.

biomarker

In addition to being a drug target, RBMXL3 may also be a good biomarker. Because its function and expression levels change in different diseases, it can be used to detect and monitor disease progression. For example, some researchers have found that RBMXL3 expression levels can be used to predict the rate of progression of Parkinson's disease.

Conclusion

RBMXL3 is a gene that encodes a protein involved in various cellular processes. Its function and remain regulation poorly understood, but its potential as a drug target and biomarker make it an important molecule to study. Further research is needed to fully understand the role of RBMXL3 in various diseases and to develop effective treatments.

Protein Name: RBMX Like 3

The "RBMXL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBMXL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL | RBPJP2 | RBPMS | RBPMS-AS1 | RBPMS2 | RBSN | RBX1 | RC3H1 | RC3H2 | RCAN1 | RCAN2 | RCAN3 | RCAN3AS | RCBTB1 | RCBTB2 | RCC1 | RCC1L | RCC2 | RCCD1 | RCE1 | RCHY1 | RCL1 | RCN1 | RCN1P2 | RCN2 | RCN3 | RCOR1 | RCOR2 | RCOR3 | RCSD1 | RCVRN | RD3 | RD3L | RDH10 | RDH11 | RDH12 | RDH13 | RDH14 | RDH16 | RDH5 | RDH8 | RDM1 | RDUR | RDX | RDXP2 | Reactive oxygen species (ROS) | REC114 | REC8 | RECK | RECQL | RECQL4 | RECQL5 | REELD1 | REEP1 | REEP2 | REEP3 | REEP4 | REEP5 | REEP6 | REG1A | REG1B | REG1CP | REG3A | REG3G | REG4 | REL | REL-DT | RELA | Relaxin | Relaxin receptor | RELB | RELCH | RELL1 | RELL2 | RELN | RELT | REM1 | REM2 | REN | RENBP | REP15 | Repeat-binding factor | REPIN1 | Replication factor C | Replication Protein A Complex (RPA) | REPS1